BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen M, Zhu B, Chen D, Hu X, Xu X, Shen WJ, Hu C, Li J, Qu S. COVID-19 May Increase the Risk of Insulin Resistance in Adult Patients Without Diabetes: A 6-Month Prospective Study. Endocr Pract 2021;27:834-41. [PMID: 33887468 DOI: 10.1016/j.eprac.2021.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mine K, Nagafuchi S, Mori H, Takahashi H, Anzai K. SARS-CoV-2 Infection and Pancreatic β Cell Failure. Biology (Basel) 2021;11:22. [PMID: 35053020 DOI: 10.3390/biology11010022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Chandrashekhar Joshi S, Pozzilli P. COVID-19 Induced Diabetes: A Novel Presentation. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.110034] [Reference Citation Analysis]
3 Das L, Bhadada SK. COVID-19-associated new-onset hyperglycaemia: a reversible entity or persistent risk? Postgrad Med J 2021:postgradmedj-2021-140807. [PMID: 34348990 DOI: 10.1136/postgradmedj-2021-140807] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lu L, Feng P, Yu M, Chen M, Lin AJ, Chen JL, Yu LH. Current utilization of interferon alpha for the treatment of coronavirus disease 2019: a comprehensive review. Cytokine & Growth Factor Reviews 2022. [DOI: 10.1016/j.cytogfr.2022.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Chang Y, Jeon J, Song T, Kim J. Association of triglyceride-glucose index with prognosis of COVID-19: A population-based study. Journal of Infection and Public Health 2022;15:837-44. [DOI: 10.1016/j.jiph.2022.06.014] [Reference Citation Analysis]
6 Gryczyńska W, Litvinov N, Bitew B, Bartosz Z, Kośmider W, Bogdański P, Skrypnik D. Excess Body Mass-A Factor Leading to the Deterioration of COVID-19 and Its Complications-A Narrative Review. Viruses 2021;13:2427. [PMID: 34960696 DOI: 10.3390/v13122427] [Reference Citation Analysis]
7 Yonekawa A, Shimono N. Clinical Significance of COVID-19 and Diabetes: In the Pandemic Situation of SARS-CoV-2 Variants including Omicron (B.1.1.529). Biology (Basel) 2022;11:400. [PMID: 35336774 DOI: 10.3390/biology11030400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mahmudpour M, Vahdat K, Keshavarz M, Nabipour I. The COVID-19-diabetes mellitus molecular tetrahedron. Mol Biol Rep 2022. [PMID: 35067816 DOI: 10.1007/s11033-021-07109-y] [Reference Citation Analysis]